These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 35936794)

  • 1. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
    Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
    Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "One-stop shop": safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation.
    Zhang ZH; Yao Q; Huang HY; Zhu P; Xu X; Song ZY; Li HK
    BMC Cardiovasc Disord; 2020 Oct; 20(1):444. PubMed ID: 33045999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
    Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
    Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
    Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia.
    Snijder RJR; Renes LE; Swaans MJ; Suttorp MJ; Ten Berg JM; Post MC
    J Interv Cardiol; 2020; 2020():1462140. PubMed ID: 32982607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
    Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
    Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
    Manolis AS; Koulouris S; Rouska E; Pyrros J
    Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-less patent foramen ovale closure by radiofrequency thermal energy.
    Walpoth NB; Habermacher K; Moarof I; Watson S; Wahl A; Windecker S; Schönenberger C; Meier B
    Swiss Med Wkly; 2008 Feb; 138(7-8):108-13. PubMed ID: 18293120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder.
    Bartakian S; El-Said HG; Printz B; Moore JW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):974-80. PubMed ID: 24050864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
    Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and efficacy of left atrial appendage closure combined with patent foramen ovale closure for atrial fibrillation patients with patent foramen ovale].
    Zhao ZH; Song X; Wang SH; Luo J; Wu YB; Zhu Q; Fang M; Huan Q; Zhang XG; Tian B; Gu W; Zhu LN; Hao SW; Ning ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):257-262. PubMed ID: 35340144
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.